Review



gen. iii microarray laser scanner  (Molecular Dynamics Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Molecular Dynamics Inc gen. iii microarray laser scanner
    Gen. Iii Microarray Laser Scanner, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gen. iii microarray laser scanner/product/Molecular Dynamics Inc
    Average 90 stars, based on 1 article reviews
    gen. iii microarray laser scanner - by Bioz Stars, 2026-05
    90/100 stars

    Images



    Similar Products

    gen. iii microarray laser scanner  (Molecular Dynamics Inc)
    90
    Molecular Dynamics Inc gen. iii microarray laser scanner
    Gen. Iii Microarray Laser Scanner, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gen. iii microarray laser scanner/product/Molecular Dynamics Inc
    Average 90 stars, based on 1 article reviews
    gen. iii microarray laser scanner - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    gen iii microarray laser scanner  (Molecular Dynamics Inc)
    86
    Molecular Dynamics Inc gen iii microarray laser scanner
    Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the <t>microarray</t> data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein <t>C-III</t> (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.
    Gen Iii Microarray Laser Scanner, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gen iii microarray laser scanner/product/Molecular Dynamics Inc
    Average 86 stars, based on 1 article reviews
    gen iii microarray laser scanner - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the microarray data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein C-III (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.

    Journal: The Journal of Lipid Research

    Article Title: Prediction of PPAR- ligand-mediated physiological changes using gene expression profiles

    doi: 10.1194/jlr.d300239-jlr200

    Figure Lengend Snippet: Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the microarray data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein C-III (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.

    Article Snippet: The slide was scanned in a Gen. III microarray laser scanner (Molecular Dynamics).

    Techniques: Comparison, Expressing, Northern Blot, Microarray, Functional Assay